These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 18844829
1. A QUEST begins. Oyama MA. J Vet Intern Med; 2008; 22(5):1076-8. PubMed ID: 18844829 [No Abstract] [Full Text] [Related]
2. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. de Madron E, King JN, Strehlau G, White RV. Can Vet J; 2011 Nov; 52(11):1219-25. PubMed ID: 22547843 [Abstract] [Full Text] [Related]
3. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2008 Nov; 22(5):1124-35. PubMed ID: 18638016 [Abstract] [Full Text] [Related]
4. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial. Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P. J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080 [Abstract] [Full Text] [Related]
5. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease. Boswood A, Smith S, Patteson M. Vet Rec; 2011 Feb 26; 168(8):222. PubMed ID: 21493561 [No Abstract] [Full Text] [Related]
6. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease. Hezzell MJ, Block CL, Laughlin DS, Oyama MA. J Vet Intern Med; 2018 Sep 26; 32(5):1509-1516. PubMed ID: 30216549 [Abstract] [Full Text] [Related]
7. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD. J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955 [Abstract] [Full Text] [Related]
8. [ACE inhibitors in dogs with subclinical chronic mitral insufficiency]. Kvart C, Häggström J, Pedersen HD. Tijdschr Diergeneeskd; 2003 Feb 01; 128(3):76-7. PubMed ID: 12616901 [No Abstract] [Full Text] [Related]
9. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. Mizuno M, Yamano S, Chimura S, Hirakawa A, Takusagawa Y, Sawada T, Maetani S, Takahashi A, Mizuno T, Harada K, Shinoda A, Uchida S, Takeuchi J, Mizukoshi T, Endo M, Uechi M. J Vet Med Sci; 2017 Jan 20; 79(1):29-34. PubMed ID: 27644192 [Abstract] [Full Text] [Related]
10. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease. Boswood A, McEwan JD, French A, Little C, Swift S, Smith S, Patteson M. Vet Rec; 2003 Oct 04; 153(14):439-40. PubMed ID: 14582738 [No Abstract] [Full Text] [Related]
11. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease. Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J. J Small Anim Pract; 2005 Mar 04; 46(3):121-30. PubMed ID: 15789807 [Abstract] [Full Text] [Related]
12. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases. Kittleson M, Rishniw M, Pion P, Kass P. J Vet Intern Med; 2009 Mar 04; 23(5):953-4; author reply 955-6. PubMed ID: 19737176 [No Abstract] [Full Text] [Related]
13. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease". Corcoran B, Culshaw G, Dukes-McEwan J, French A, Smith S, Swift S. J Vet Intern Med; 2008 Mar 04; 22(2):243; author reply 245. PubMed ID: 18371020 [No Abstract] [Full Text] [Related]
15. Pimobendan in heart failure therapy--a silver bullet? Gordon SG, Miller MW, Saunders AB. J Am Anim Hosp Assoc; 2006 Mar 04; 42(2):90-3. PubMed ID: 16527909 [Abstract] [Full Text] [Related]
16. Treatment of congestive heart failure. Butson R. J Small Anim Pract; 2003 Nov 04; 44(11):516. PubMed ID: 14635966 [No Abstract] [Full Text] [Related]
19. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded and randomized study". Le Bobinnec G. J Vet Intern Med; 2008 Nov 04; 22(2):243-4; author reply 245-6. PubMed ID: 18371019 [No Abstract] [Full Text] [Related]